Pralsetinib

CHEBI:CHEBI_751811

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2394947
generic_name
Pralsetinib SDD intermediate
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
route
ORAL
active_ingredient_strength
.5 kg/kg
dosage_form
CAPSULE
labeler_name
VALARY LAB PRIVATE LIMITED
manufacturer_name
Genentech, Inc.
package_marketing_start_date
07-DEC-22
marketing_start_date
20221207
nui
N0000193947
pharm_class_epc
Kinase Inhibitor [EPC]
pharm_class
Rearranged during Transfection (RET) Inhibitors [MoA]
pharm_class_moa
Rearranged during Transfection (RET) Inhibitors [MoA]
brand_name
Gavreto
brand_name_base
Gavreto
product_ndc
50909-1905
application_number
NDA213721
spl_id
ea860b5f-0fa5-4b54-bad8-8a8dcfe6912a
active_ingredient_name
PRALSETINIB
package_ndc
50909-1905-1
package_description
8 kg in 1 PACKAGE (50909-1905-1)
unii
1WPE73O1WV
spl_set_id
16edd46e-28b8-f06d-e063-6394a90ae31b
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class